Teitur Trophics
Edward Browne is the Chief Development Officer at Teitur Tropics since November 2023. Prior to this role, Edward held positions at various companies such as Swansea University, Eliem Therapeutics, ICON plc, Sygnature Discovery, GSK, and Simbec Research Ltd, gaining substantial experience in DMPK and toxicology. With a PhD in Analytical Chemistry from Swansea University, Edward has a strong background in supporting drug discovery programs and establishing high performing teams in the pharmaceutical research industry.
This person is not in any teams
This person is not in any offices
Teitur Trophics
Teitur develops novel therapeutics for treating or preventing neurodegenerative diseases. Teitur is Old Norse for happiness. Our ambition and commitment is to create new treatments for patients suffering from neurodegenerative diseases to help them live a longer, better and happier life.